Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Sara Harrysson; Sandra Eloranta; Sara Ekberg; Gunilla Enblad; Per Ola Andersson; Kristina Sonnevi; Maria Ljungqvist; Birgitta Sander; Mats Jerkeman; Karin E. Smedby

doi:10.1080/10428194.2023.2296361

Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman, Karin E. Smedby

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	534-537
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	65
Issue number	4
DOIs	https://doi.org/10.1080/10428194.2023.2296361
Publication status	Published - 2024

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2023.2296361

Cite this

Harrysson, S., Eloranta, S., Ekberg, S., Enblad, G., Andersson, P. O., Sonnevi, K., Ljungqvist, M., Sander, B., Jerkeman, M., & Smedby, K. E. (2024). Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy. Leukemia and Lymphoma, 65(4), 534-537. https://doi.org/10.1080/10428194.2023.2296361

@article{1c5456bc60bf4c1eba1a12fa3e733be8,

title = "Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy",

author = "Sara Harrysson and Sandra Eloranta and Sara Ekberg and Gunilla Enblad and Andersson, \{Per Ola\} and Kristina Sonnevi and Maria Ljungqvist and Birgitta Sander and Mats Jerkeman and Smedby, \{Karin E.\}",

year = "2024",

doi = "10.1080/10428194.2023.2296361",

language = "English",

volume = "65",

pages = "534--537",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor \& Francis",

number = "4",

}

Harrysson, S, Eloranta, S, Ekberg, S, Enblad, G, Andersson, PO, Sonnevi, K, Ljungqvist, M, Sander, B, Jerkeman, M & Smedby, KE 2024, 'Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy', Leukemia and Lymphoma, vol. 65, no. 4, pp. 534-537. https://doi.org/10.1080/10428194.2023.2296361

TY - JOUR

T1 - Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

AU - Harrysson, Sara

AU - Eloranta, Sandra

AU - Ekberg, Sara

AU - Enblad, Gunilla

AU - Andersson, Per Ola

AU - Sonnevi, Kristina

AU - Ljungqvist, Maria

AU - Sander, Birgitta

AU - Jerkeman, Mats

AU - Smedby, Karin E.

PY - 2024

Y1 - 2024

UR - https://www.scopus.com/pages/publications/85180699912

U2 - 10.1080/10428194.2023.2296361

DO - 10.1080/10428194.2023.2296361

M3 - Letter

C2 - 38134325

AN - SCOPUS:85180699912

SN - 1042-8194

VL - 65

SP - 534

EP - 537

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Subject classification (UKÄ)

UN SDGs

Access to Document

Other files and links

Cite this